| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |